Cargando…
Long-COVID: Phase 2 of the COVID-19 Pandemic
Autores principales: | Goetzl, Edward J., Kapogiannis, Dimitrios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376974/ https://www.ncbi.nlm.nih.gov/pubmed/35981646 http://dx.doi.org/10.1016/j.amjmed.2022.07.017 |
Ejemplares similares
-
Prediction of Post-Acute-Sequelae of COVID-19 by Cargo Protein Biomarkers of Blood Total Extracellular Vesicles in Acute COVID-19
por: Goetzl, Edward J., et al.
Publicado: (2023) -
Mitochondrial Electron Transport Chain Protein Abnormalities Detected in Plasma Extracellular Vesicles in Alzheimer’s Disease
por: Yao, Pamela J., et al.
Publicado: (2021) -
Biomarker-Drug and Liquid Biopsy Co-development for Disease Staging and Targeted Therapy: Cornerstones for Alzheimer’s Precision Medicine and Pharmacology
por: Hampel, Harald, et al.
Publicado: (2019) -
Neuron-Derived Exosome Proteins May Contribute to Progression From Repetitive Mild Traumatic Brain Injuries to Chronic Traumatic Encephalopathy
por: Goetzl, Edward J., et al.
Publicado: (2019) -
Emergency department leadership considerations for the next phase of the COVID-19 pandemic
por: Rosenberg, Hans, et al.
Publicado: (2023)